Hardy D J
Department of Microbiology and Immunology, University of Rochester Medical Center, New York 14642-8710.
Am J Med. 1991 Dec 30;91(6A):12S-14S. doi: 10.1016/0002-9343(91)90302-e.
The microbiologic activities of temafloxacin, ciprofloxacin, and ofloxacin against community-acquired respiratory tract pathogens are reviewed. The 90% minimal inhibitory concentrations (MIC90s) of these fluoroquinolones for gram-negative pathogens were generally comparable, that is, less than 0.06 micrograms/mL. Overall, the agents were less active against gram-positive pathogens, although temafloxacin was two- to fourfold more active than the other agents against staphylococci and streptococci. For strains of Mycoplasma pneumoniae and Chlamydia pneumoniae, temafloxacin was generally inhibitory at concentrations of 0.5-2 micrograms/mL. This microbiologic activity, combined with its pharmacokinetic profile, should make temafloxacin a useful antimicrobial agent for treating community-acquired respiratory tract infections.
本文综述了替马沙星、环丙沙星和氧氟沙星对社区获得性呼吸道病原体的微生物学活性。这些氟喹诺酮类药物对革兰氏阴性病原体的90%最小抑菌浓度(MIC90)通常相当,即低于0.06微克/毫升。总体而言,这些药物对革兰氏阳性病原体的活性较低,尽管替马沙星对葡萄球菌和链球菌的活性比其他药物高两到四倍。对于肺炎支原体和肺炎衣原体菌株,替马沙星通常在浓度为0.5 - 2微克/毫升时具有抑制作用。这种微生物学活性及其药代动力学特征,应使替马沙星成为治疗社区获得性呼吸道感染的有用抗菌药物。